Show simple item record

Immunoregulatory dysfunctions in type I diabetes: Natural and antibody-dependent cellular cytotoxic activities

dc.contributor.authorNair, Madhavan P. N.en_US
dc.contributor.authorLewis, Eric W.en_US
dc.contributor.authorSchwartz, Stanley A.en_US
dc.date.accessioned2006-09-11T15:21:19Z
dc.date.available2006-09-11T15:21:19Z
dc.date.issued1986-09en_US
dc.identifier.citationNair, Madhavan P. N.; Lewis, Eric W.; Schwartz, Stanley A.; (1986). "Immunoregulatory dysfunctions in type I diabetes: Natural and antibody-dependent cellular cytotoxic activities." Journal of Clinical Immunology 6(5): 363-372. <http://hdl.handle.net/2027.42/44848>en_US
dc.identifier.issn1573-2592en_US
dc.identifier.issn0271-9142en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/44848
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2429979&dopt=citationen_US
dc.description.abstractPeripheral blood lymphocytes from 13 patients with established insulin-dependent diabetes mellitus (IDDM) and 2 prediabetic patients were examined for natural killer (NK) and antibody-dependent cellular cytotoxic activities (ADCC), lectin-dependent cellular cytotoxicity (LDCC), interferon- and interleukin-2-induced cytotoxicity, and concanavalin A-induced suppressor-cell activities in comparison with age-matched normal controls. IDDM patients demonstrated normal levels of NK and ADCC activities against K562 and antibody-coated SB target cells, respectively, compared to controls. IDDM patients showed normal levels of LDCC activity. Notable deviations from control values were, however, observed with diabetic lymphocytes in the following systems. Interferon-and interleukin-2-induced NK activities were significantly higher with IDDM lymphocytes than with control cells. IDDM lymphocytes precultured with concanavalin A demonstrated lower NK and ADCC activities than control cells and manifested decreased suppressor effects on the NK activity of normal allogeneic lymphocytes. Lymphocytes from one of two prediabetic patients showed increased NK, ADCC, and LDCC activities in comparison to controls. The increased interferon- and interleukin-2-induced enhancement of NK activity and reduced suppressor activity of lymphocytes from IDDM patients may be involved in the pathogenesis of the disease.en_US
dc.format.extent1234853 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherKluwer Academic Publishers-Plenum Publishers; Plenum Publishing Corporation ; Springer Science+Business Mediaen_US
dc.subject.otherInternal Medicineen_US
dc.subject.otherInterferonen_US
dc.subject.otherImmunoregulationen_US
dc.subject.otherInsulin-dependent Diabetes Mellitusen_US
dc.subject.otherBiomedicineen_US
dc.subject.otherImmunologyen_US
dc.subject.otherMedical Microbiologyen_US
dc.subject.otherInfectious Diseasesen_US
dc.subject.otherPrediabetesen_US
dc.subject.otherNatural Killer Cellsen_US
dc.subject.otherInterleukin-2en_US
dc.titleImmunoregulatory dysfunctions in type I diabetes: Natural and antibody-dependent cellular cytotoxic activitiesen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMicrobiology and Immunologyen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pediatrics, The University of Michigan, 48109, Ann Arbor, Michigan; Department of Epidemiology, The University of Michigan, 48109, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDepartment of Pediatrics, The University of Michigan, 48109, Ann Arbor, Michigan; Department of Epidemiology, The University of Michigan, 48109, Ann Arbor, Michigan; The University of Michigan, 109 South Observatory, Room 1029 SPH-I, 48109, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDepartment of Internal Medicine, The University of Michigan, 48109, Ann Arbor, Michiganen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid2429979en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/44848/1/10875_2004_Article_BF00915375.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/BF00915375en_US
dc.identifier.sourceJournal of Clinical Immunologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.